drugset / Trial / NCT02446834

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

NCT02446834

Completed 40 enrolled RenJi Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

Compare the efficacy between intensive lifestyle intervention and drugs (GLP-1 Receptor Agonists, metformin and acarbose) for PCOS patients with early onset diabetes in their metabolic and reproductive abnormalities treatment; clear the treatment effect and mechanism of intensive lifestyle intervention to PCOS.

Timeline

Start
2015-04
Primary completion
2017-12
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acarbose Unknown
Subject Metformin Small molecule